MASLD is the hepatic manifestation of the MS which is often associated with abnormal liver enzyme levels such as elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (10, 11). The gene discussed is GPT; the disease is myeloid sarcoma.